SEC Form 4 · accession 0001140361-15-035076

Arbutus Biopharma Corp · ABUS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Managing Director

Period of report

Sep 11, 2015

Accepted (ET)

Sep 15, 2015 · 4:18 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001447028

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares^F1	Sep 11, 2015	M	17,044	$0.4444	A	27,919	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$0.4444	Sep 11, 2015	M	17,044	D	Mar 30, 2008	Sep 12, 2015	Common shares	17,044	0	D